haloperidol has been researched along with dynorphins in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (42.86) | 18.7374 |
| 1990's | 9 (42.86) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krause, JE; Sivam, SP | 1 |
| Fiorica-Howells, E; Spector, S | 1 |
| Nylander, I; Terenius, L | 1 |
| Gaudreau, P; Martel, JC; Quirion, R; St-Pierre, S; Zamir, N | 1 |
| Hong, JS; Li, S; Sivam, SP | 1 |
| Hong, JS; Sivam, SP; Smith, DR; Takeuchi, K | 1 |
| Calvetta, L; Civelli, O; Douglass, J; Herbert, E; Hong, JS; Li, S; McGinty, JF; Sivam, SP; Takeuchi, K | 1 |
| Höllt, V | 1 |
| Billington, CJ; Gerritsen, GC; Levine, AS; Morley, JE | 1 |
| Peterson, MR; Robertson, HA | 1 |
| Grace, M; Kneip, J; Levine, AS; Morley, JE | 1 |
| Egan, MF; Hurd, Y; Hyde, TM; Kleinman, JE; Weinberger, DR; Wyatt, RJ | 1 |
| Chaĭdo, MA; Devoĭno, LV; Idova, GV | 1 |
| Bonastre, M; Chase, TN; Engber, TM; Marin, C; Tolosa, E | 1 |
| Bachus, SE; Egan, MF; Ferguson, J; Hamid, EH; Hurd, Y; Hyde, TM | 1 |
| Fibiger, HC; Guo, N; Vincent, SR | 1 |
| Cheĭdo, MA; Idova, GV | 1 |
| Besson, MJ; Mavridis, M | 1 |
| Beaudry, G; Langlois, MC; Lévesque, D; Rouillard, C; Weppe, I | 1 |
| De Souza, IE; Egan, MF; Hyde, TM; Meredith, GE; Tipper, G; Wong, ML | 1 |
| Cohen, BM; Lange, N; Ma, J; Ye, N | 1 |
21 other study(ies) available for haloperidol and dynorphins
| Article | Year |
|---|---|
Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.
Topics: Animals; Animals, Newborn; Basal Ganglia; Blotting, Northern; Capsaicin; Chromatography, High Pressure Liquid; Dopamine Agents; Dynorphins; Endorphins; Female; Haloperidol; Injections, Subcutaneous; Neurokinin A; Neurons; Neurotoxins; Pregnancy; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Neurotransmitter; RNA, Messenger; Spinal Cord; Substance P; Tachykinins | 1992 |
Selectivity of some "specific" opioid ligands?
Topics: Animals; Benzomorphans; Binding, Competitive; Brain; Dynorphins; Female; Haloperidol; In Vitro Techniques; Mice; Morphinans; Peptide Fragments; Phencyclidine; Piperidines; Receptors, Opioid | 1990 |
Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat.
Topics: Animals; Basal Ganglia; Body Weight; Clozapine; Dibenzazepines; Dynorphins; Haloperidol; Injections, Intraperitoneal; Male; Protein Precursors; Radioimmunoassay; Rats; Rats, Inbred Strains; Substance P | 1986 |
Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
Topics: Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Dynorphins; Endorphins; Enkephalin, Leucine; Enkephalin, Methionine; Globus Pallidus; Haloperidol; Male; Putamen; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system.
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Dynorphins; Haloperidol; Male; Peptide Fragments; Rats; Rats, Inbred F344; Substantia Nigra; Synaptic Transmission | 1986 |
Lithium and haloperidol differentially alter the dynorphin A (1-8) and enkephalin levels in the neurointermediate lobe of rat pituitary.
Topics: Animals; Dynorphins; Enkephalins; Haloperidol; Lithium; Male; Peptide Fragments; Pituitary Gland; Rats; Rats, Inbred F344 | 1987 |
Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats.
Topics: Animals; Basal Ganglia; Chlorides; Corpus Striatum; Dose-Response Relationship, Drug; Dynorphins; Enkephalins; Gene Expression Regulation; Genes; Haloperidol; Immunoenzyme Techniques; Lithium; Lithium Carbonate; Lithium Chloride; Male; Peptide Fragments; Protein Precursors; Rats; Rats, Inbred F344; RNA, Messenger; Transcription, Genetic | 1988 |
Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
Topics: Animals; Antipsychotic Agents; beta-Endorphin; Brain; Dynorphins; Endorphins; Enkephalin, Methionine; Enkephalins; Haloperidol; Pituitary Gland; Rats; Receptors, Dopamine; Receptors, Opioid; Synaptic Transmission | 1981 |
Feeding systems in Chinese hamsters.
Topics: Animals; Brain; Calcitonin; Circadian Rhythm; Cricetinae; Cyclazocine; Diabetes Mellitus; Dynorphins; Eating; Endorphins; Ethylketocyclazocine; Feeding Behavior; Haloperidol; Mesocricetus; Naloxone; Peptide Fragments; Phenazocine; Sincalide; Starvation | 1984 |
Effect of dopaminergic agents on levels of dynorphin1-8 in rat striatum.
Topics: Animals; Corpus Striatum; Dextroamphetamine; Dynorphins; Haloperidol; Male; Phencyclidine; Radioimmunoassay; Rats; Rats, Inbred Strains | 1984 |
Dynorphin-(1-13), dopamine and feeding in rats.
Topics: Animals; Bromocriptine; Dopamine; Dynorphins; Eating; Endorphins; Haloperidol; Male; Narcotics; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid | 1982 |
Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.
Topics: Animals; Basal Ganglia Diseases; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Glutamate Decarboxylase; Haloperidol; In Situ Hybridization; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P | 1994 |
[The serotonin-dependent suppression of the immune response by kappa-opiate receptors].
Topics: Animals; Cyproheptadine; Dose-Response Relationship, Drug; Dynorphins; Endorphins; Haloperidol; Immune Tolerance; Immunization; Mice; Mice, Inbred CBA; Pituitary Gland; Receptors, Opioid, kappa; Receptors, Serotonin; Serotonin | 1993 |
Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behavior.
Topics: Animals; Behavior, Animal; Dopamine Agonists; Dopamine Antagonists; Dynorphins; Enkephalins; Haloperidol; Male; Neostriatum; Neuropeptides; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sensitivity and Specificity; Somatostatin; Stereotyped Behavior; Substance P; Time Factors | 1996 |
Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Corpus Striatum; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Haloperidol; In Situ Hybridization; Male; Mastication; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P | 1996 |
Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: contrasting targets of haloperidol and clozapine.
Topics: Animals; Antipsychotic Agents; Clozapine; Dopamine D2 Receptor Antagonists; Dynorphins; Enkephalins; Haloperidol; In Situ Hybridization; Male; Neurons; Oligonucleotide Probes; Organ Specificity; Phenotype; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Transcription, Genetic | 1998 |
[Effect of opioid peptides on immunomodulation].
Topics: Animals; Cyproheptadine; Dopamine D2 Receptor Antagonists; Dynorphins; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalins; Haloperidol; Male; Mice; Mice, Inbred CBA; Neuroimmunomodulation; Pituitary Gland; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, Serotonin; Spleen | 1998 |
Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
Topics: Animals; Dopamine; Dopamine Antagonists; Dynorphins; Enkephalins; Globus Pallidus; Glutamate Decarboxylase; Haloperidol; Male; Naloxone; Narcotic Antagonists; Neostriatum; Neurons; Opioid Peptides; Protein Precursors; Rats; Rats, Wistar; Receptors, Opioid, mu; RNA, Messenger | 1999 |
Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain.
Topics: Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; DNA-Binding Proteins; Drug Administration Schedule; Dynorphins; Enkephalins; Gene Expression Regulation; Haloperidol; In Situ Hybridization; Male; Neurons; Neurotensin; Nuclear Receptor Subfamily 4, Group A, Member 1; Nucleus Accumbens; Organ Specificity; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors | 2000 |
Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Dendrites; Disease Models, Animal; Dynorphins; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Microscopy, Electron; Neurons; Nucleus Accumbens; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Synapses | 2000 |
Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus.
Topics: Acetylcholine; Amygdala; Animals; Antipsychotic Agents; Astrocytes; Clozapine; Dynorphins; Enkephalin, Methionine; Fluorescent Antibody Technique; gamma-Aminobutyric Acid; Haloperidol; Intralaminar Thalamic Nuclei; Neural Inhibition; Neurons; Nucleus Accumbens; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2003 |